Francis LeBlanc

1.1k total citations
15 papers, 377 citations indexed

About

Francis LeBlanc is a scholar working on Immunology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Francis LeBlanc has authored 15 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Francis LeBlanc's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immune Cell Function and Interaction (5 papers). Francis LeBlanc is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immune Cell Function and Interaction (5 papers). Francis LeBlanc collaborates with scholars based in United States, France and Italy. Francis LeBlanc's co-authors include Thomas P. Loughran, Wei Ding, Hanning You, Shelly C. Lu, Bangyan L. Stiles, Hien Dang, Steven N. Steinway, David J. Feith, Dan Zhang and Xin Liu and has published in prestigious journals such as Blood, Hepatology and CHEST Journal.

In The Last Decade

Francis LeBlanc

14 papers receiving 374 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Francis LeBlanc 171 133 115 109 102 15 377
Sameer A. Greenall 203 1.2× 43 0.3× 47 0.4× 125 1.1× 142 1.4× 22 424
Hsu-Ping Kuo 174 1.0× 150 1.1× 123 1.1× 72 0.7× 186 1.8× 10 409
Francesca Cottino 112 0.7× 48 0.4× 85 0.7× 66 0.6× 283 2.8× 11 426
Oleg Schmidt-Kittler 152 0.9× 138 1.0× 27 0.2× 51 0.5× 89 0.9× 10 364
Luke B. Fletcher 168 1.0× 61 0.5× 42 0.4× 71 0.7× 64 0.6× 16 328
Emma Arriola 276 1.6× 81 0.6× 79 0.7× 70 0.6× 170 1.7× 9 465
Esther A. Beuling 255 1.5× 274 2.1× 211 1.8× 291 2.7× 133 1.3× 10 696
Nicola D. Roberts 238 1.4× 37 0.3× 91 0.8× 133 1.2× 86 0.8× 7 554
Viktor Ljungström 139 0.8× 54 0.4× 110 1.0× 127 1.2× 70 0.7× 23 323
Nguyen Tan 343 2.0× 48 0.4× 63 0.5× 67 0.6× 179 1.8× 7 460

Countries citing papers authored by Francis LeBlanc

Since Specialization
Citations

This map shows the geographic impact of Francis LeBlanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis LeBlanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis LeBlanc more than expected).

Fields of papers citing papers by Francis LeBlanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis LeBlanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis LeBlanc. The network helps show where Francis LeBlanc may publish in the future.

Co-authorship network of co-authors of Francis LeBlanc

This figure shows the co-authorship network connecting the top 25 collaborators of Francis LeBlanc. A scholar is included among the top collaborators of Francis LeBlanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis LeBlanc. Francis LeBlanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
LeBlanc, Francis, Erin H. Breese, Karen Burns, et al.. (2024). Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. British Journal of Haematology. 205(3). 1055–1066. 3 indexed citations
2.
LeBlanc, Francis, et al.. (2023). Targeting CREB-Binding Protein (CREBBP) Overcomes Resistance to Azacitidine and Venetoclax Therapy in Acute Myeloid Leukemia (AML). Blood. 142(Supplement 1). 5765–5765. 1 indexed citations
3.
LeBlanc, Francis, Zainul S. Hasanali, August Stuart, et al.. (2022). Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma. Oncotarget. 13(1). 986–1002.
4.
Humbert, Marc, Francis LeBlanc, Renato Zambello, et al.. (2020). Large Granular Lymphocyte Leukemia and Precapillary Pulmonary Hypertension. CHEST Journal. 158(6). 2602–2609. 7 indexed citations
5.
Russi, Abigail E., et al.. (2020). Pediatric Patient With Ulcerative Colitis-Associated Bronchiectasis. ACG Case Reports Journal. 7(4). e00365–e00365. 4 indexed citations
6.
LeBlanc, Francis, Jennifer M. Pearson, Su‐Fern Tan, et al.. (2020). Sphingosine kinase‐2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl‐1. British Journal of Haematology. 190(3). 405–417. 24 indexed citations
7.
Spurgeon, Stephen E., Kamal Sharma, David F. Claxton, et al.. (2019). Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma. British Journal of Haematology. 186(6). 845–854. 19 indexed citations
8.
Yang, Jun, Francis LeBlanc, Cait E. Hamele, et al.. (2018). TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia. Blood. 131(25). 2803–2815. 32 indexed citations
9.
10.
LeBlanc, Francis, Xin Liu, Jeremy A. Hengst, et al.. (2015). Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia. Cancer Biology & Therapy. 16(12). 1830–1840. 23 indexed citations
11.
Poullot, Elsa, Renato Zambello, Francis LeBlanc, et al.. (2014). Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. Annals of Oncology. 25(10). 2030–2035. 45 indexed citations
12.
Steinway, Steven N., Francis LeBlanc, & Thomas P. Loughran. (2014). The pathogenesis and treatment of large granular lymphocyte leukemia. Blood Reviews. 28(3). 87–94. 50 indexed citations
13.
LeBlanc, Francis, Dan Zhang, Xin Liu, & Thomas P. Loughran. (2012). Large Granular Lymphocyte Leukemia: From Dysregulated Pathways to Therapeutic Targets. Future Oncology. 8(7). 787–801. 27 indexed citations
14.
Ding, Wei, Hanning You, Hien Dang, et al.. (2010). Epithelial-to-Mesenchymal Transition of Murine Liver Tumor Cells Promotes Invasion†,‡. Hepatology. 52(3). 945–953. 135 indexed citations
15.
Johnson, R. E. & Francis LeBlanc. (2001). The Physics and Chemistry of Sputtering by Energetic Plasma Ions. Astrophysics and Space Science. 277(1-2). 259–269. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sameer A. Greenall Breakdown of academic impact, for papers by Hsu-Ping Kuo Breakdown of academic impact, for papers by Francesca Cottino Breakdown of academic impact, for papers by Oleg Schmidt-Kittler Breakdown of academic impact, for papers by Luke B. Fletcher Breakdown of academic impact, for papers by Emma Arriola Breakdown of academic impact, for papers by Esther A. Beuling Breakdown of academic impact, for papers by Nicola D. Roberts Breakdown of academic impact, for papers by Viktor Ljungström Breakdown of academic impact, for papers by Nguyen Tan
Rankless by CCL
2026